Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Optive and Restasis in Dry Eye
NCT00405457Phase 4Completed
- Sponsor
- Janssen Pharmaceutical
- Start
- Nov 2006
- Primary completion
- Jan 2008
- Modality
- Polymer-based Nanoparticles, Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of carboxymethylcellulose sodium + glycerin in dry eye syndrome (DED), sponsored by Janssen Pharmaceutical. Primary endpoint: Ocular Surface Disease Index at 15 months. Started Nov 2006; status: completed.
02
Drugs
carboxymethylcellulose sodium + glycerin
03
Conditions
dry eye syndrome (DED)
Beyond the preview
Go deeper on NCT00405457.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00405457.